1
|
Raverdy V, Chatelain E, Lasailly G, Caiazzo R, Vandel J, Verkindt H, Marciniak C, Legendre B, Bauvin P, Oukhouya-Daoud N, Baud G, Chetboun M, Vantyghem MC, Gnemmi V, Leteurtre E, Staels B, Lefebvre P, Mathurin P, Marot G, Pattou F. Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study. Obesity (Silver Spring) 2023; 31:3066-3076. [PMID: 37987186 DOI: 10.1002/oby.23904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 07/13/2023] [Accepted: 07/30/2023] [Indexed: 11/22/2023]
Abstract
OBJECTIVE Steatotic liver disease (SLD) is frequent in individuals with obesity. In this study, type 2 diabetes (T2D), sex, and menopausal status were combined to refine the stratification of obesity regarding the risk of advanced SLD and gain further insight into disease physiopathology. METHODS This study enrolled 1446 participants with obesity from the ABOS cohort (NCT01129297), who underwent extensive phenotyping, including liver histology and transcriptome profiling. Hierarchical clustering was applied to classify participants. The prevalence of metabolic disorders associated with steatohepatitis (NASH) and liver fibrosis (F ≥ 2) was determined within each identified subgroup and aligned to clinical and biological characteristics. RESULTS The prevalence of NASH and F ≥ 2 was, respectively, 9.5% (N = 138/1446) and 11.7% (N = 159/1365) in the overall population, 20.3% (N = 107/726) and 21.1% (N = 106/502) in T2D patients, and 3.4% (N = 31/920) and 6.1% (N = 53/863) in non-T2D patients. NASH and F ≥ 2 prevalence was 15.4% (33/215) and 15.5% (32/206) among premenopausal women with T2D vs. 29.5% (33/112) and 30.3% (N = 36/119) in postmenopausal women with T2D (p < 0.01); and 21.0% (21/100) / 27.0% (24/89) in men with T2D ≥ age 50 years and 17.9% (17/95) / 18.5% (17/92) in men with T2D < age 50 years (NS). The distinct contribution of menopause was confirmed by the interaction between sex and age with respect to NASH among T2D patients (p = 0.048). Finally, several NASH-associated biological traits (lower platelet count; higher serum uric acid; gamma-glutamyl transferase; aspartate aminotransferase) and liver expressed genes AKR1B10 and CCL20 were significantly associated with menopause in women with T2D but not with age in men with T2D. CONCLUSIONS This study unveiled a remarkably high prevalence of advanced SLD after menopause in women with T2D, associated with a dysfunctional biological liver profile.
Collapse
Affiliation(s)
- Violeta Raverdy
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
| | - Estelle Chatelain
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, Lille, France
| | - Guillaume Lasailly
- University Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France
| | - Robert Caiazzo
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Jimmy Vandel
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, Lille, France
| | - Helene Verkindt
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Camille Marciniak
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Benjamin Legendre
- University Lille, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
| | - Pierre Bauvin
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
| | - Naima Oukhouya-Daoud
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Gregory Baud
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Mikael Chetboun
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| | - Marie-Christine Vantyghem
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
| | - Viviane Gnemmi
- University Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France
- Department of Pathology, CHU Lille, Lille, France
| | - Emmanuelle Leteurtre
- University Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France
- Department of Pathology, CHU Lille, Lille, France
| | - Bart Staels
- University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France
| | - Philippe Lefebvre
- University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France
| | - Philippe Mathurin
- University Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France
| | - Guillemette Marot
- University Lille, CHU Lille, ULR 2694-METRICS: Evaluation des technologies de santé et des pratiques médicales, Lille, France
- Inria, MODAL, MOdels for Data Analysis and Learning, Lille, France
| | - Francois Pattou
- University Lille, Lille, France
- European Genomic Institute for Diabetes, Lille, France
- INSERM, UMR 1190, Translational Research for Diabetes, Lille, France
- CHU Lille, Integrated Center for Obesity, Lille, France
- General and Endocrine Surgery, CHU Lille, Lille, France
| |
Collapse
|
2
|
Tang B, Roberts SM, Clark JS, Gelfand AE. Mechanistic modeling of climate effects on redistribution and population growth in a community of fish species. Glob Chang Biol 2023; 29:6399-6414. [PMID: 37789712 DOI: 10.1111/gcb.16963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 09/01/2023] [Accepted: 09/19/2023] [Indexed: 10/05/2023]
Abstract
Understanding community responses to climate is critical for anticipating the future impacts of global change. However, despite increased research efforts in this field, models that explicitly include important biological mechanisms are lacking. Quantifying the potential impacts of climate change on species is complicated by the fact that the effects of climate variation may manifest at several points in the biological process. To this end, we extend a dynamic mechanistic model that combines population dynamics, such as species interactions, with species redistribution by allowing climate to affect both processes. We examine their relative contributions in an application to the changing biomass of a community of eight species in the Gulf of Maine using over 30 years of fisheries data from the Northeast Fishery Science Center. Our model suggests that the mechanisms driving biomass trends vary across space, time, and species. Phase space plots demonstrate that failing to account for the dynamic nature of the environmental and biologic system can yield theoretical estimates of population abundances that are not observed in empirical data. The stock assessments used by fisheries managers to set fishing targets and allocate quotas often ignore environmental effects. At the same time, research examining the effects of climate change on fish has largely focused on redistribution. Frameworks that combine multiple biological reactions to climate change are particularly necessary for marine researchers. This work is just one approach to modeling the complexity of natural systems and highlights the need to incorporate multiple and possibly interacting biological processes in future models.
Collapse
Affiliation(s)
- Becky Tang
- Department of Mathematics and Statistics, Middlebury College, Middlebury, Vermont, USA
- Department of Statistical Science, Duke University, Durham, North Carolina, USA
| | - Sarah M Roberts
- Department of Earth, Marine, and Environmental Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - James S Clark
- Nicholas School of the Environment, Duke University, Durham, North Carolina, USA
| | - Alan E Gelfand
- Department of Statistical Science, Duke University, Durham, North Carolina, USA
| |
Collapse
|